Patents by Inventor Abigail Hunt

Abigail Hunt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and Methods to Regulate Renalase in the Treatment of Cancer
    Publication number: 20220281996
    Abstract: The invention provides compositions and methods for binding and inhibiting renalase. In one embodiment, the renalase binding molecule inhibits renalase activity. Thus, in diseases and conditions where a reduction of renalase activity is beneficial, such inhibitory renalase binding molecules act as therapeutics.
    Type: Application
    Filed: May 9, 2022
    Publication date: September 8, 2022
    Inventors: Gary Desir, Abigail Hunt, Jessica O-Rear, Peter Flynn
  • Compositions and methods to regulate Renalase in the treatment of cancer
    Patent number: 11370846
    Abstract: The invention provides compositions and methods for binding and inhibiting renalase. In one embodiment, the renalase binding molecule inhibits renalase activity. Thus, in diseases and conditions where a reduction of renalase activity is beneficial, such inhibitory renalase binding molecules act as therapeutics.
    Type: Grant
    Filed: April 14, 2020
    Date of Patent: June 28, 2022
    Assignee: Yale University
    Inventors: Gary Desir, Abigail Hunt, Jessica O-Rear, Peter Flynn
  • Compositions and Methods to Regulate Renalase in the Treatment of Cancer
    Publication number: 20210024652
    Abstract: The invention provides compositions and methods for binding and inhibiting renalase. In one embodiment, the renalase binding molecule inhibits renalase activity. Thus, in diseases and conditions where a reduction of renalase activity is beneficial, such inhibitory renalase binding molecules act as therapeutics.
    Type: Application
    Filed: April 14, 2020
    Publication date: January 28, 2021
    Inventors: Gary Desir, Abigail Hunt, Jessica O-Rear, Peter Flynn
  • Antibody to Renalase
    Patent number: 10618975
    Abstract: The invention provides compositions and methods for binding and inhibiting renalase. In one embodiment, the renalase binding molecule inhibits renalase activity. Thus, in diseases and conditions where a reduction of renalase activity is beneficial, such inhibitory renalase binding molecules act as therapeutics.
    Type: Grant
    Filed: March 7, 2019
    Date of Patent: April 14, 2020
    Assignee: YALE UNIVERSITY
    Inventors: Gary Desir, Abigail Hunt, Jessica O-Rear, Peter Flynn
  • Compositions and Methods to Regulate Renalase in the Treatment of Cancer
    Publication number: 20190194355
    Abstract: The invention provides compositions and methods for binding and inhibiting renalase. In one embodiment, the renalase binding molecule inhibits renalase activity. Thus, in diseases and conditions where a reduction of renalase activity is beneficial, such inhibitory renalase binding molecules act as therapeutics.
    Type: Application
    Filed: March 7, 2019
    Publication date: June 27, 2019
    Inventors: Gary Desir, Abigail Hunt, Jessica O-Rear, Peter Flynn
  • Compositions to regulate renalase in the treatment of diseases and disorders
    Patent number: 10273311
    Abstract: The invention provides compositions and methods for binding and inhibiting renalase. In one embodiment, the renalase binding molecule inhibits renalase activity. Thus, in diseases and conditions where a reduction of renalase activity is beneficial, such inhibitory renalase binding molecules act as therapeutics.
    Type: Grant
    Filed: June 26, 2015
    Date of Patent: April 30, 2019
    Assignee: YALE UNIVERSITY
    Inventors: Gary Desir, Abigail Hunt, Jessica O-Rear, Peter Flynn
  • Compositions and Methods to Regulate Renalase in the Treatment of Diseases and Disorders
    Publication number: 20170226228
    Abstract: The invention provides compositions and methods for binding and inhibiting renalase. In one embodiment, the renalase binding molecule inhibits renalase activity. Thus, in diseases and conditions where a reduction of renalase activity is beneficial, such inhibitory renalase binding molecules act as therapeutics.
    Type: Application
    Filed: June 26, 2015
    Publication date: August 10, 2017
    Inventors: Gary Desir, Abigail Hunt, Jessica O-Rear, Peter Flynn